|
Summary Information: Adverum Biotechnologies Inc. Common Stock NASDAQ:ADVM |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is advancing the clinical development of its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration and diabetic macular edema.
__The following are links to various summary and news pages for __Adverum Biotechnologies Inc. Common Stock [ ADVM ]. __Note: Some Links might not have information for the company. |
|